Table 1: Clinical characteristics

 

Variable

Group 1 (n = 132)

Hyperuricemia

Group 2 (n = 28)

Free of hyperuricemia

P

Age at Transplant

3.1 9.7

35.5 11.9

0.07

Female n, %

55 (40)

11 (39)

0.87

Hypertension n, %

98 (72)

21 (75)

0.75

Diabetes Mellitus n, %

15 (11)

4 (14)

0.51

Dyslipidemia n, %

80 (58)

10 (35)

0.02

Body Mass Index

23.1 4.1

22.4 2.8

0.29

Cyclosplorine A n, %

118 (86)

21 (75)

0.13

Mycophenolate mofetil n, %

58 (42)

2 (7)

0.001

Azathioprine n, %

126 (92)

24 (85)

0.43

Tacrolimus n, %

20 (14)

7 (25)

0.24